| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3293545 | Gastroenterology | 2012 | 20 Pages |
Abstract
In vitro reactivity can be restored to T cells from patients with suppressed HBV infection following long-term treatment with nucleos(t)ide analogues, despite prolonged exposure to large loads of antigen. Immune therapies that increase the antiviral T-cell response might increase the likelihood of complete HBV control in patients undergoing long-term nucleos(t)ide analogue treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Carolina Boni, Diletta Laccabue, Pietro Lampertico, Tiziana Giuberti, Mauro Viganò, Simona Schivazappa, Arianna Alfieri, Marco Pesci, Giovanni B. Gaeta, Giuseppina Brancaccio, Massimo Colombo, Gabriele Missale, Carlo Ferrari,